Development and Initial Testing of a Couple-Based Intervention to Optimize Suicide and Self-Injury Treatment: COMPASS (Connecting, Overcoming, and Moving Past Suicide and Self-Injury) (COMPASS)

• ClinicalTrials.gov Identifier: NCT04737252
• Recruitment Status: Recruiting
• First Posted: February 3, 2021
• Last Update Posted: June 8, 2021
• Sponsor: York University
• Collaborator: Ryerson University
• Information provided by (Responsible Party): Skye Fitzpatrick, York University

Study Description

Brief Summary:

Self-injurious thoughts and behaviors (SITBs), including suicide, thinking about suicide, and self-injury without intent to die, are major public health crises, with variably effective, and sometimes long and expensive, interventions. SITBs are particularly common in borderline personality disorder (BPD). Moreover, people with BPD often cannot access SITB treatment, drop out of them, and may lose their improvements after them. Reducing SITBs in BPD requires innovative interventions that have greater impact and are faster to deliver. SITBs are particularly influenced by emotion dysregulation (i.e., intense, negative emotion and difficulties changing it) and intimate relationship dysfunction, but leading evidence-based SITB interventions typically focus on the former, while neglecting the latter. For other mental health problems, couple treatments result in comparable or better individual outcomes relative to individually-delivered treatments, with added benefits of enhanced intimate relationship functioning. SITB treatment outcomes in BPD could likely be expedited and optimized with a couple intervention that targets emotion dysregulation in a relational context and intimate relationship dysfunction. This project aims to develop, refine, and test a brief SITB intervention delivered conjointly to individuals with BPD and SITBs (i.e., "patients") and their intimate partners (i.e., "partners")- COMPASS (Connecting, Overcoming, and Moving Past Suicide and Self- injury)- that targets both emotion dysregulation and intimate relationship dysfunction to reduce SITBs and BPD symptoms in the short- and long-term. Prior to formal testing in an uncontrolled trial, it is important to solicit preliminary data regarding the clarity, accessibility, safety, tolerability, and efficacy of COMPASS. This project involves 3 Phases: translating COMPASS outlines into a manual (Phase 1); refining COMPASS (Phase 2); and an uncontrolled pilot trial of COMPASS (Phase 3). In Phase 1, the three stages of COMPASS will be manualized to focus on (1) developing a conjoint safety plan to reduce SITB risk, (2) reducing emotion dysregulation and intimate relationship dysfunction, and (3) changing patterns that maintain SITBs. In Phase 2, COMPASS will be delivered to 5-10 patients with BPD and SITBs and their partners (i.e., 5-10 couples) who will provide feedback about whether COMPASS is clear, helpful, and useable. This feedback will be used to refine the COMPASS manual. In Phase 3, the investigators will test whether COMPASS is safe, initially efficacious, and feasible by administering it to 15-20 patients with BPD and SITB and their partners (i.e., 15-20 couples). The investigators will examine whether COMPASS results in changes in SITBs and BPD symptoms in patients with BPD and SITBs, and SITB risk factors (e.g., emotion dysregulation and intimate relationship dysfunction) in both patients and partners. These outcomes will be measured multiple times per day during treatment using participant's smartphones (i.e., ecological momentary assessment), and interviews/questionnaires administered at the beginning, middle, end, and at 3 months after the intervention. The investigators predict that COMPASS will reduce SITBs and BPD symptoms in the patient with BPD and SITBs and improve emotion dysregulation and intimate relationship dysfunction in both patients with BPD and SITBs and their partners. This study offers a novel SITB and BPD treatment that directly targets SITBs, BPD symptoms, and the factors that drive them. Its short duration broadens the accessibility of BPD and SITB interventions with the potential to contribute to reducing SITBs and BPD symptoms on a large scale. During this period of social distancing due to COVID-19, COMPASS will be delivered remotely via secure videoconferencing (Zoom Healthcare). As social distancing restrictions lift, COMPASS will be delivered in the laboratory.

Condition or disease	Intervention/treatment	Phase
Self-injurious Thoughts and Behaviours; Borderline Personality Disorder	Behavioral: Connecting, Overcoming and Moving Past Suicide and Self-Injury	Not Applicable

Study Design

• Study Type: Interventional (Clinical Trial)
• Estimated Enrollment: 40 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Intervention Model Description: Uncontrolled pilot trial
• Masking: None (Open Label)
• Primary Purpose: Treatment
• Official Title: Development and Initial Testing of a Couple-Based Intervention to Optimize Suicide and Self-Injury Treatment: COMPASS (Connecting, Overcoming, and Moving Past Suicide and Self-Injury)
• Actual Study Start Date: January 18, 2021
• Estimated Primary Completion Date: September 30, 2022
• Estimated Study Completion Date: September 30, 2022

Arms and Interventions

Arm

Intervention/treatment

Experimental: COMPASS; Immediately receives 8-12 sessions of couple intervention aimed to improve self-injury thoughts and behaviours, emotion dysregulation, borderline personality disorder symptoms, and intimate relationship dysfunction.

Behavioral: Connecting, Overcoming and Moving Past Suicide and Self-Injury; COMPASS is a remote 8-12 session intervention for couples wherein one individual has Borderline Personality Disorder (BPD) and engages in self-injury thoughts and behaviours. The intervention consists of elements of Cognitive Behavioural Conjoint Therapy (CBCT) and has been adapted for this population. Couples will meet remotely with a clinician (registered psychologists and/or graduate level clinicians) for 8-12 sessions via Zoom Healthcare. The primary outcomes are self-injury thoughts and behaviours (as measured by the Suicide Attempt and Self-Injury Interview-modified, and the Beck Scale for Suicidal Ideation and ecological momentary assessment) and borderline personality disorder symptoms (as measured by the Borderline Symptom List-23).

Outcome Measures

Primary Outcome Measures :

1. Changes in the frequency and intensity of self-injury thoughts and behaviours from baseline will be examined through ecological momentary assessment. [ Time Frame: It will be administered daily (three times per day) for five weeks throughout the intervention; from baseline to post intervention ]
2. Change in frequency of self-injury thoughts and behaviours from baseline, as measured by the Suicide Attempt Self-Injury Interview-modified. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
3. Change in severity of suicidal ideation from baseline, as measured by the Beck Scale for Suicidal Ideation. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Beck Scale for Suicidal Ideation has a minimum possible score of 0, and maximum possible score of 38, wherein higher scores reflect more severe suicidal ideation.
4. Changes in Borderline Personality Symptom severity from baseline, as measured by the Borderline Symptom List-23. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Borderline Symptom List-23 has a minimum possible score of 0, and maximum possible score of 92, wherein higher scores reflect more severe borderline personality disorder symptoms.
5. Changes in Borderline Personality Symptom severity from baseline, as measured by the Zanarini Rating Scale for Borderline Personality Disorder (self-report) [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Zanarini Rating Scale for Borderline Personality Disorder (self-report) has a minimum possible score of 0, and maximum possible score of 36, wherein higher scores reflect more severe borderline personality disorder symptoms.

Secondary Outcome Measures :

1. Change in severity of depression from baseline, as measured by the Patient Health Questionnaire-9. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Patient Health Questionnaire-9 has a minimum possible score of 0 and a maximum possible score of 27, wherein higher scores reflect higher severity of depression.
2. Changes is emotion dysregulation from baseline, as measured by The Difficulties in Emotion Regulation Scale (DERS). [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Difficulties in Emotion Regulation scale has a minimum possible score of 36, and maximum possible score of 180, wherein higher scores reflect greater emotion dysregulation.
3. Changes in one's report of their partner's emotion dysregulation from baseline, as measured by the Difficulties in Emotion Regulation Scale - Partner Version (DERS-Partner). [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Difficulties in Emotion Regulation Scale - Partner has a minimum possible score of 8, and maximum possible score of 40, wherein higher scores reflect more severe emotion dysregulation reported of one's partner.
4. Changes in relationship satisfaction from baseline, as measured by mean change from baseline on the Couples Satisfaction Index. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Couples Satisfaction Index has a minimum possible score of 0, and a maximum possible score of 161, wherein higher scores reflect higher levels of relationship satisfaction.

Other Outcome Measures:

1. Changes in participants psychiatric and medical treatments (e.g., medication, day treatment programs) from baseline, measured by The Mental Health Utilization Interview-Modified. [ Time Frame: It will be administered only at baseline (pre-intervention) and immediately after the intervention. ]
2. Changes in severity of conflict from baseline, as measured by the Ineffective Arguing Inventory. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Ineffective Arguing Inventory has a minimum possible score of 8, and a maximum possible score of 40, wherein higher scores indicate decreased satisfaction with the style of arguing in a relationship.
3. Changes in severity of Anxiety from baseline, as measured by Generalized Anxiety Disorder-7. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Generalized Anxiety Disorder-7 has a minimum possible score of 0 and maximum possible score of 21, wherein higher scores reflect more severe levels of anxiety.
4. Changes in Posttraumatic Stress Disorder severity from baseline, as measured by the Post-Traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). [ Time Frame: It will be administered only half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Post-Traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) has a minimum possible score of 0 and a maximum possible score of 80, wherein higher scores reflect more severe posttraumatic stress disorder symptomatology.
5. Changes in one's report of their partner's Borderline Personality Symptoms severity from baseline, as measured by the Borderline Symptom List-23 - Partner Report. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
6. Changes in suicidal ideation severity from baseline, as measured by the Suicide Behaviours Questionnaire-Revised. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Suicide Behaviours Questionnaire-Revised has a minimum possible score of 3, and a maximum possible score of 18, wherein higher scores indicate more severe suicidal ideation.
7. Changes in one's report of their partner's suicidal ideation from baseline, as measured by the suicide Behaviours Questionnaire-Revised - Partner Report. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Suicide Behaviours Questionnaire-Revised - Partner Report has a minimum possible score of 3, and a maximum possible score of 18, wherein higher scores indicate more severe suicidal ideation reported of their partner.
8. Changes in emotional reactivity from baseline, as measured by the Emotional Reactivity. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
   The Emotional Reactivity Scale has a minimum possible score of 0, and a maximum possible score of 84, wherein higher scores reflect greater emotional reactivity.
9. Changes in affect from baseline, as measured by the Positive and Negative Affect Schedule-Modified. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
10. Changes in addiction severity from baseline, as measured by the Addiction Severity Index. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
11. Changes in Work, Health, and Life Quality from baseline, as measured by 3 one-item self-report measurements that assess work functioning, perceived health status, and overall quality of life. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
12. Changes in shame from baseline, as measured by the Experience of Shame Scale. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
    The Experience of Shame Scale has a minimum possible score of 25, and a maximum possible score of 100, wherein higher scores reflect higher levels of shame.
13. Frequency of Emergency Department Visits and Hospitalizations with change measured as mean change from baseline. [ Time Frame: It will be administered only at baseline (pre-intervention), half-way through intervention, immediately after the intervention, and three months after the intervention (Phase 3 only). ]
14. Client satisfaction with the intervention as measured by the Client Satisfaction Questionnaire. [ Time Frame: It will be administered only immediately after the intervention ]
    The Client Satisfaction Questionnaire has a minimum possible score of 8, and a maximum possible score of 32, wherein higher scores reflect greater satisfaction with the intervention.

Eligibility Criteria

• Ages Eligible for Study: 18 Years to 70 Years (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

1. Patients have either engaged in 2+ suicidal or non-suicidal self-injurious behaviors in the past two weeks (i.e., chronic and recent SITBs, consistent with previous research evaluating non-suicidal self-injury (Kranzler et al., 2018)), or have severe suicidal ideation as indicated by a score ≥15 on the Beck Scale for Suicidal Ideation (Beck, 1991)
2. Patients also meet diagnostic criteria for BPD
3. Patients are between the ages of 18 and 70 years-old
4. Patients have a romantic partner who is between the ages of 18 and 70 years-old
5. Patient's romantic partner is willing to participate in the study with them

Exclusion Criteria:

1. Past-year severe intimate aggression in their relationship such that participants who endorse any severe physical and/or sexual assault behaviors in the past year will be excluded from the study (Monson et al., 2012; Abramowitz et al., 2013), as assessed by the Revised Conflict Tactics Scale, Severe Items Subscale (CTS-2; Straus, Hamby, Boney-McCoy, & Sugarman, 1996)
2. Either partner has a severe substance use disorder that would interfere with the capacity to attend and participate in this study
3. Either partner has clinically significant psychotic symptoms or bipolar I disorder (e.g., McMain et al., 2018; McMain et al., 2009)
4. Either partner has a major cognitive or intellectual impairment that would prevent the individual's ability to attend intervention and participate in the research study
5. Either partner has illiteracy in English language
6. Either partner is unable or unwilling to download and use a mobile application on their smart phone to complete daily Ecological Momentary Assessment (EMA) measures
7. If partners meet inclusion criterion #1, or #2, or meet the self-harm/suicidal behaviour diagnostic criterion for BPD.
8. If either partner of the couple is unwilling to have assessments and sessions audio or videorecorded
9. If either partner is currently not residing in Ontario

Contacts and Locations

Contacts

Contact: Dr. Skye Fitzpatrick, PhD; skyefitz@yorku.ca

Contact: Sonya Varma, BSc; svarma@yorku.ca

Locations

Canada, Ontario

York University; Recruiting

Toronto, Ontario, Canada, M3J 1P3

Contact: Dr. Skye Fitzpatrick, PhD skyefitz@yorku.ca

Sponsors and Collaborators

York University

Ryerson University

Investigators

• Principal Investigator: Dr. Skye Fitzpatrick, PhD; York University

More Information

Publications:

Fitzpatrick S, Wagner AC, Monson CM. Optimizing borderline personality disorder treatment by incorporating significant others: A review and synthesis. Personal Disord. 2019 Jul;10(4):297-308. doi: 10.1037/per0000328. Epub 2019 Feb 4.

Fitzpatrick S, Liebman RE, Monson CM. The borderline interpersonal-affective systems (BIAS) model: Extending understanding of the interpersonal context of borderline personality disorder. Clin Psychol Rev. 2021 Jan 24;84:101983. doi: 10.1016/j.cpr.2021.101983. [Epub ahead of print] Review.

• Responsible Party: Skye Fitzpatrick, Assistant Professor, York University
• ClinicalTrials.gov Identifier: NCT04737252
• Other Study ID Numbers: PRG-0-057-19
• First Posted: February 3, 2021
• Last Update Posted: June 8, 2021
• Last Verified: June 2021

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: No

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Skye Fitzpatrick, York University:

Self-injury Thoughts and Behaviours; Suicide; Non-suicidal Self-injury; Couple Intervention; Emotion Dysregulation; Intimate Relationship Dysfunction; Borderline Personality Disorder

Additional relevant MeSH terms:

Suicide; Personality Disorders; Borderline Personality Disorder; Self-Injurious Behavior; Behavioral Symptoms; Mental Disorders